Cargando…

Magnetic Nanoparticles Used in Oncology

Recently, magnetic nanoparticles (MNPs) have more and more often been used in experimental studies on cancer treatments, which have become one of the biggest challenges in medical research. The main goal of this research is to treat and to cure advanced or metastatic cancer with minimal side effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Manescu (Paltanea), Veronica, Paltanea, Gheorghe, Antoniac, Iulian, Vasilescu, Marius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539633/
https://www.ncbi.nlm.nih.gov/pubmed/34683540
http://dx.doi.org/10.3390/ma14205948
_version_ 1784588794257735680
author Manescu (Paltanea), Veronica
Paltanea, Gheorghe
Antoniac, Iulian
Vasilescu, Marius
author_facet Manescu (Paltanea), Veronica
Paltanea, Gheorghe
Antoniac, Iulian
Vasilescu, Marius
author_sort Manescu (Paltanea), Veronica
collection PubMed
description Recently, magnetic nanoparticles (MNPs) have more and more often been used in experimental studies on cancer treatments, which have become one of the biggest challenges in medical research. The main goal of this research is to treat and to cure advanced or metastatic cancer with minimal side effects through nanotechnology. Drug delivery approaches take into account the fact that MNPs can be bonded to chemotherapeutical drugs, nucleic acids, synthetized antibodies or radionuclide substances. MNPs can be guided, and different treatment therapies can be applied, under the influence of an external magnetic field. This paper reviews the main MNPs’ synthesis methods, functionalization with different materials and highlight the applications in cancer therapy. In this review, we describe cancer cell monitorization based on different types of magnetic nanoparticles, chemotherapy, immunotherapy, magnetic hyperthermia, gene therapy and ferroptosis. Examples of applied treatments on murine models or humans are analyzed, and glioblastoma cancer therapy is detailed in the review. MNPs have an important contribution to diagnostics, investigation, and therapy in the so called theranostics domain. The main conclusion of this paper is that MNPs are very useful in different cancer therapies, with limited side effects, and they can increase the life expectancy of patients with cancer drug resistance.
format Online
Article
Text
id pubmed-8539633
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85396332021-10-24 Magnetic Nanoparticles Used in Oncology Manescu (Paltanea), Veronica Paltanea, Gheorghe Antoniac, Iulian Vasilescu, Marius Materials (Basel) Review Recently, magnetic nanoparticles (MNPs) have more and more often been used in experimental studies on cancer treatments, which have become one of the biggest challenges in medical research. The main goal of this research is to treat and to cure advanced or metastatic cancer with minimal side effects through nanotechnology. Drug delivery approaches take into account the fact that MNPs can be bonded to chemotherapeutical drugs, nucleic acids, synthetized antibodies or radionuclide substances. MNPs can be guided, and different treatment therapies can be applied, under the influence of an external magnetic field. This paper reviews the main MNPs’ synthesis methods, functionalization with different materials and highlight the applications in cancer therapy. In this review, we describe cancer cell monitorization based on different types of magnetic nanoparticles, chemotherapy, immunotherapy, magnetic hyperthermia, gene therapy and ferroptosis. Examples of applied treatments on murine models or humans are analyzed, and glioblastoma cancer therapy is detailed in the review. MNPs have an important contribution to diagnostics, investigation, and therapy in the so called theranostics domain. The main conclusion of this paper is that MNPs are very useful in different cancer therapies, with limited side effects, and they can increase the life expectancy of patients with cancer drug resistance. MDPI 2021-10-10 /pmc/articles/PMC8539633/ /pubmed/34683540 http://dx.doi.org/10.3390/ma14205948 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Manescu (Paltanea), Veronica
Paltanea, Gheorghe
Antoniac, Iulian
Vasilescu, Marius
Magnetic Nanoparticles Used in Oncology
title Magnetic Nanoparticles Used in Oncology
title_full Magnetic Nanoparticles Used in Oncology
title_fullStr Magnetic Nanoparticles Used in Oncology
title_full_unstemmed Magnetic Nanoparticles Used in Oncology
title_short Magnetic Nanoparticles Used in Oncology
title_sort magnetic nanoparticles used in oncology
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539633/
https://www.ncbi.nlm.nih.gov/pubmed/34683540
http://dx.doi.org/10.3390/ma14205948
work_keys_str_mv AT manescupaltaneaveronica magneticnanoparticlesusedinoncology
AT paltaneagheorghe magneticnanoparticlesusedinoncology
AT antoniaciulian magneticnanoparticlesusedinoncology
AT vasilescumarius magneticnanoparticlesusedinoncology